Diagnosis dan Tatalaksana Juvenile Idiopathic Arthritis
DOI:
https://doi.org/10.55175/cdk.v48i3.46Keywords:
Juvenile Idiopathic ArthritisAbstract
Juvenile Idiopathic Arthritis (JIA) merupakan kondisi inflamasi kronik pada anak, terjadi pada usia < 16 tahun pada setidaknya 1 sendi selama kurang lebih 6 bulan tanpa penyebab lain. Insidens JIA 1-22 per 100.000 dan prevalensi 7-150 per 100.000. Diagnosis JIA cukup sulit karena tidak ada pemeriksaan penunjang spesifik. Berdasarkan The International League of Associations for Rheumatology (ILAR), ada 7 jenis JIA. Tatalaksana JIA menggunakan 2011 American College of Rheumatology (ACR) Recommendations, dengan rekomendasi tahun 2019 untuk klasifikasi non-systemic polyarthritis, sacroilitis, dan enthesitis.
Juvenile Idiopathic Arthritis (JIA) is a chronic inflammatory condition in children, specific at <16 years of age in at least 1 joint for approximately 6 months without any other cause of joint inflammation. The incidence is 1-22 per 100,000 and prevalence is 7-150 per 100,000. Diagnosis is quite difficult because of no specific investigation and the clinical manifestations and symptoms are similar to various other diseases. Based on The International League of Associations for Rheumatology (ILAR), JIA is categorized into 7 types. Management use the 2011 American College of Rheumatology (ACR) Recommendations, with new 2019 recommendation for non-systemic polyarthritis, sacroilitis and enthesitis.
Downloads
References
Al-Mayouf SM. Noninflammatory Disorder Mimic Juvenile Idiopathic Arthritis. Internat J Pediatr Adolescent Med. 2018: 1-4. [Available from: https://www.researchgate.net/publication/323380715_Noninflammatory_disorders_mimic_juvenile_idiopathic_arthritis] [cited 2020 June 17]
Scott C, Brice N. Juvenile Idiopathic Arthritis- An Update on Its Diagnosis and Management. S Afr Med J. 2015; 105(12):1-7. [Available from: https://www.researchgate.net/publication/285357848_Juvenile_idiopathic_arthritis_-_An_update_on_its_diagnosis_and_management] [cited 2020 June 17]
Giancane G, Consolaro A, Lanni S, Davi S, Schiappapietra, Ravelli A. Juvenile Idiopathic Arthritis: Diagnosis and Treatment. Rheumatol Ther. 2016;3(2):187-207. [cited 2020 June 17]; [Available from: https://pubmed.ncbi.nlm.nih.gov/27747582/]
Barut K, Adrovic A, Sahin S, Kasapcopur O. Juvenile Idiopathic Arthritis. Balkan Med J. 2017;34(2):90-101. [Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394305/[ cited 2020 June 17]
ADA’s Medical Knowledge Team (2020 February 14). Juvenile Idiopathic Arthritis.. [Available from: https://ada.com/conditions/juvenile-idiopathic-arthritis/][cited 2020 June 17]
Horton DB, Susan S. Review of Environmental Factors and Juvenile Idiopathic Arthritis. Open Access Rheumatology: Research and Reviews. 2019; 11: 253-267.[Available from: https://www.dovepress.com/review-of-environmental-factors-and-juvenile-idiopathic-arthritis-peer-reviewed-article-OARRR] [cited 2020 June 17]
Ghrahani R, Setiabudiawan B, Sapartini G, Puspasari H. Distribusi Subtipe Juvenile Idiopathic Arthritis di Bandung. MKB. 2012; 44(2): 101-105. [Available from: http://journal.fk.unpad.ac.id/index.php/mkb/article/view/78] [cited 2020 June 17]
Jacobson JL, Jennifer T. Juvenile Idiopathic Arthritis: A Focus on Pharmacologic Management. J Pediatr Health Care. 2018;32(5):515-528. [Available from: https://pubmed.ncbi.nlm.nih.gov/30177013/][cited 2020 June 17]
Shenoi S. Juvenile Idiopathic Arthritis – Changing Times, Changing Terms, Changing Treatments. Pediatr in Rev. 2017; 38(5): 221-232. [Available from: https://pedsinreview.aappublications.org/content/38/5/221] [cited 2020 June 17]
Hahn YS, Kim JG. Pathogenesis and Clinical Manifestations of Juvenile Rheumatoid Arthritis. Korean J Pediatr. 2010; 53(11): 921-30. [Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012271/][cited 2020 June 17]
Nelson MR. Buschbacher RM. Rehabilitation Medicine Quick Reference, Pediatrics. New York: Demos Medical Publishing. 2011
Joe GO, Hicks JE, Gerber LH. Rehabilitation of the Patient with Rheumatic Diseases. In: Frontera WR, chief editor. Delisa’s Physical Medicine & Rehabilitation, Principles and Practice. 5thed. vol 1. Philadelphia: Lippincot Williams & Wilkins, a Wolters Kluwer Business.; 2010. p. 1015-1073
Ravelli A, Schiappapietra B, Verazza S, Martini A. Juvenile Idiopathic Arthritis. In: Nussinovitch U, eds. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases. Elsevier: Academic Press. 2017
Espinosa M, Gottlieb BS. Juvenile Idiopathic Arthritis. Pediatrics In Review.; 33(7): 303-13. [Available from: https://pedsinreview.aappublications.org/content/33/7/303.long] 2012 [cited 2020 June 18]
Beukelman T., Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ruperto N. 2011 American College of Rheumatology Recommendations for The Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features. Arthritis Care Res. 2011; 63: 465-82. [Available from: https://www.rheumatology.org/Portals/0/Files/2011%20ACR%20Recommendations%20for%20the%20Treatment%20of%20Juvenile%20Idiopathic%20Arthritis.pdf ] [cited 2020 June 19]
Harris JG, Kessler EA, & Verbsky JW. Update on The Treatment of Juvenile Idiopathic Arthritis. Curr Allerg & Asthma Reports. 2013; 13: 337-346. [Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729726/][cited 2020 June 19]
Kim KN. Treatment of Juvenille Rheumatoid Arthritis. Korean J Pediatr. 2010; 53(11): 936-41. [Available from: https://www.e-cep.org/journal/view.php?doi=10.3345/kjp.2010.53.11.936] [cited 2020 June 20]
Ringold S, et.al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroilitis and Enthesitis. Arthritis Care Res. 2019; 71(6): 717-34. [Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561125/][cited 2020 June 20]
Nijhof LN, Nap-van der Vlist MM, van de Putte EM, van Royen-Kerkhof A, Nijhof SL. Non-Pharmacological Options for Managing Chronic Musculoskeletal pain in Childern with Pediatric Rheumatic Disease: a Systematic Review. Rheumatol Internat. 2018; 38: 2015-25. [Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208689/][cited 2020 June 21]
Cunningham NR, Kashikar-Zuck S. Nonpharmacological Treatment of Pain in Rheumatic Diseases and Other Musculoskeletal Pain Conditions. Curr Rheumatol Rep. 2013; 15(2): 306. [Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566663/][cited 2020 July 24]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Cermin Dunia Kedokteran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
